Monica Maurer Sost

Mrs. Monica Maurer Sost

Maastricht University – Campus Venlo, Centre of healthy Eating & Food Innovation, St. Jansweg 20, 5928 RC Venlo, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Monica Maurer SostMonica Maurer Sost
Monica Maurer Sost
SASanne Ahles
Sanne Ahles
JVJessica Verhoeven
Jessica Verhoeven
SVSanne Verbruggen
Sanne Verbruggen
YSYala Stevens
Yala Stevens
KVKoen Venema
Koen Venema
The effect of a Citrus Fruit Extract high in the polyphenols hesperidin and naringin (CFE) on modulation of the composition and activity of the gut microbiota was tested in a validated, dynamic in vitro model of the colon (TIM-2). CFE was provided at two doses (250 and 350 mg/day) for 3 days. CFE led to a dose-dependent increase in Roseburia, Eubacterium ramulus, and Bacteroides eggerthii. There was a shift in production of short-chain fatty acids, where acetate production increased on CFE, while butyrate decreased. In overweight and obesity, acetate has been shown to increase fat oxidation when produced in the distal gut, and stimulate secretion of appetite-suppressive neuropeptides. Thus, the data in the in vitro model point towards mechanisms underlying the effects of the polyphenols in CFE with respect to modulation of the gut microbiota, both in composition and activity. These results should be confirmed in a clinical trial.

13 September 2023 in Foods
Verified
Journal Article
Open access
PDF file
Monica Maurer SostMonica Maurer Sost
Monica Maurer Sost
YSYala Stevens
Yala Stevens
BSBouke Salden
Bouke Salden
FTFreddy Troost
Freddy Troost
AMA.A.M. Masclee
A.A.M. Masclee
KVKoen Venema
Koen Venema
The objective of this study was to investigate the effects of a citrus extract rich in citrus flavonoids on intestinal metabolic responses in subjects with features of metabolic syndrome, in an in vitro colon fermentation system (TIM-2) and fecal samples obtained from human subjects in an in vivo trial. In the TIM-2 system inoculated with fecal samples of volunteers with features of metabolic syndrome, continuous citrus extract supplementation (500 mg/day) resulted in increased cumulative short-chain fatty acid (SCFA) levels compared to the control condition, which was mainly due to increased production of butyrate, acetate, and valerate. In human volunteers, 12 weeks of daily supplementation with 500 mg citrus extract resulted in a significant shift in the SCFA profile towards more butyrate (p = 0.022) compared to the placebo group. Furthermore, there was a trend towards a reduction in fecal calprotectin levels, a marker for intestinal inflammation, compared to the placebo (p = 0.058). Together, these results suggest that citrus extract intake may have a positive effect on intestinal metabolic responses and through this, on host health in subjects with features of metabolic syndrome. Further research is needed to provide more insight into the potential underlying mechanisms and to study effects on clinical parameters.

27 November 2023 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
IPIgor Popov
Igor Popov
NMNaiana Einhardt Manzke
Naiana Einhardt Manzke
Monica Maurer SostMonica Maurer Sost
Monica Maurer Sost
JVJessica Verhoeven
Jessica Verhoeven
SVSanne Verbruggen
Sanne Verbruggen
KVKoen Venema
Koen Venema
Phytogenic feed additives are gaining popularity in livestock as a replacement for antibiotic growth promotors. Some phytogenic blends (PB) positively affect the production performance, inhibit pathogens within the gut microbiota, and improve the overall health of farm animals. In this study, a swine large intestine in vitro model was used to evaluate the effect of two PBs, alone or in combination with casein, on swine gut microbiota. As a result, the combination of casein with PB1 had the most beneficial effects on swine gut microbiota, as it increased the relative abundance of some commensal bacteria and two genera (Lactobacillus and Oscillospiraceae UCG-002), which are associated with greater production performance in pigs. At the same time, supplementation with PBs did not lead to an increase in opportunistic pathogens, indicating their safety for pigs. Both PBs showed fewer changes in swine gut microbiota compared to interventions with added casein. In contrast, casein supplementation significantly increased beta diversity and the relative abundance of commensal as well as potentially beneficial bacteria. In conclusion, the combination of casein with PBs, in particular PB1, had the most beneficial effects among the studied supplements in vitro, with respect to microbiota modulation and metabolite production, although this data should be proven in further in vivo studies.

20 August 2026 in Beneficial Microbes
Verified
Journal Article
Open access
PDF file
Monica Maurer SostMonica Maurer Sost
Monica Maurer Sost
JBJ.J.A.J. Bastings
J.J.A.J. Bastings
AUA. Umanets
A. Umanets
JHJ.A. Harrold
J.A. Harrold
JHJ.C.G. Halford
J.C.G. Halford
EBEllen Blaak
Ellen Blaak
The consumption of sweeteners and sweetness enhancers (S&SE) has increased over the past decades. Recent literature indicates controversies regarding the safety of sweetener consumption, concerning effects on gut microbial composition and related adverse alterations in metabolic health. In the present study, we aimed to determine the effects of three non-caloric sweeteners (saccharin, sucralose, and stevia rebaudioside A) on the composition and functionality of the gut microbiota using a validated in vitro model of the human colon. Over a 72 h intervention period, pooled microbiota from individuals with overweight was cultivated in a simulated ileal efflux medium (SIEM) with a standard carbohydrate mix (control) or one of the three sweeteners. Gut microbial composition was determined in lumen samples, and organic acid concentrations were measured in lumen and dialysis samples. There were no significant differences in alpha and beta diversities between S&SE or SIEM over time. Both saccharin and sucralose increased the abundance of potential SCFA-producing bacterial genera, such as Oscillospiraceae_003 , undetermined genus belonging to Ruminococcaceae family, Barnesiella , Butyricicoccus , and Coprobacter , compared to the control condition, but changes were not significant after multiple testing adjustment. However, the highest SCFA production was observed in SIEM in comparision with the S&SE tested (208.0 mmol for SIEM vs. 134.9 mmol for sucralose, 124.8 mmol for rebaudioside A, and 115.5 mmol for saccharin). Although SCFA levels were lower in gut microbiota exposed to S&SE than under SIEM, SCFA production increased over time across all S&SE products. Among the S&SE, sucralose yielded the highest concentrations of acetate (50.4 mmol), short-chain fatty acids (134.9 mmol) and branched-chain fatty acids (11.5 mmol). There are distinct effects of non-caloric S&SE on gut microbiota composition and function. Future research should determine whether these effects can be translated to in vivo conditions and investigate the link to metabolic health.